We believe nothing replaces human ingenuity. Our product works as a collaborative co-expert, creating a symbiotic relationship that amplifies commercial judgment with AI capability.

Our product respects the regulatory boundaries pharma requires, while creating the shared context they need to execute in the next era of complex launches.

priseAI was co-founded by Indira Gillingham and Philip Terbay, who first met at Deloitte Consulting.

With decades of experience bringing innovative technology to scale across complex and regulated enterprises, they set out to go beyond passive software to build AI that collaborates with context on consequential knowledge work.